What is the minimum percentage requirement for accrual to clinical trials in pediatric cancer programs?

The minimum percentage requirement for accrual to clinical trials in pediatric cancer programs is 30%. This standard is established to ensure that pediatric cancer programs actively participate in clinical research, which is vital for advancing treatment options and improving outcomes for children with cancer. By requiring a minimum accrual percentage, the Commission on Cancer emphasizes the importance of enrolling a significant proportion of patients in clinical trials, facilitating the collection of robust data needed for evidence-based practices and potential new therapies tailored for younger patients. This focus on substantial participation in clinical trials helps ensure that the unique aspects of pediatric cancer care are addressed through research specifically designed for this vulnerable population.